Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam

Am J Cardiol. 2002 Apr 15;89(8):999-1002. doi: 10.1016/s0002-9149(02)02259-2.

Authors

Annapoorna S Kini¹, Cristina A Mitre, Mazullah Kamran, Javed Suleman, Michael Kim, Mary E Duffy, Jonathan D Marmur, Samin K Sharma

Affiliation

¹ Cardiac Catheterization Laboratory of the Cardiovascular Institute, Mount Sinai School of Medicine, New York, New York, USA.

PMID: 11950448
DOI: 10.1016/s0002-9149(02)02259-2

No abstract available

MeSH terms

Aged
Atherectomy, Coronary
Cardiac Catheterization
Contrast Media / adverse effects*
Diabetic Nephropathies / complications*
Dopamine Agonists / therapeutic use*
Female
Fenoldopam / therapeutic use*
Humans
Incidence
Kidney Diseases / chemically induced*
Kidney Diseases / prevention & control
Kidney Failure, Chronic / complications*
Male
Risk Factors
Stents
Triiodobenzoic Acids / adverse effects*

Substances

Contrast Media
Dopamine Agonists
Triiodobenzoic Acids
Fenoldopam
ioversol